{
    "root": "13b98f50-4a4d-45a6-8e91-03dbb401bc68",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "HYDROCORTISONE VALERATE",
    "value": "20250320",
    "ingredients": [
        {
            "name": "HYDROCORTISONE VALERATE",
            "code": "68717P8FUZ"
        },
        {
            "name": "CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)",
            "code": "4Q93RCW27E"
        },
        {
            "name": "SODIUM PHOSPHATE, DIBASIC, ANHYDROUS",
            "code": "22ADO53M6F"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "STEARETH-2",
            "code": "V56DFE46J5"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "STEARETH-100",
            "code": "4OH5W9UM87"
        },
        {
            "name": "STEARYL ALCOHOL",
            "code": "2KR89I4H1Y"
        },
        {
            "name": "PETROLATUM",
            "code": "4T6H12BN9U"
        }
    ],
    "indications": "Hydrocortisone valerate cream USP is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients.",
    "contraindications": "Hydrocortisone valerate cream should be applied to the affected area as a thin film two or three times daily depending on the severity of the condition.\n                  As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. Hydrocortisone valerate cream should not be used with occlusive dressings unless directed by a physician. Hydrocortisone valerate cream should not be applied in the diaper area if the patient requires diapers or plastic pants as these garments may constitute occlusive dressing.",
    "warningsAndPrecautions": "Hydrocortisone valerate cream USP, 0.2%, is supplied in 15 g (NDC 68180-954-01), 45 g (NDC 68180-954-02) and 60 g (NDC 68180-954-03) tube sizes.\n                  \n                     Storage\n                  \n                  Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].\n                  LUPIN and the  are registered trademarks of Lupin Pharmaceuticals, Inc.",
    "adverseReactions": "Hydrocortisone valerate cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation."
}